apixaban NDC 14445-149

NDC codes

FDA NDC Directory

Product NDC (as listed)14445-149Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14445-0149Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
14445-149-05	14445014905	500 TABLET, FILM COATED in 1 BOTTLE (14445-149-05)Marketed from Sep 16, 2020
14445-149-10	14445014910	1 TABLET, FILM COATED in 1 CARTON (14445-149-10)Marketed from Sep 16, 2020
14445-149-14	14445014914	1 TABLET, FILM COATED in 1 CARTON (14445-149-14)Marketed from Sep 16, 2020
14445-149-18	14445014918	180 TABLET, FILM COATED in 1 BOTTLE (14445-149-18)Marketed from Sep 16, 2020
14445-149-60	14445014960	60 TABLET, FILM COATED in 1 BOTTLE (14445-149-60)Marketed from Sep 16, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): apixaban
Generic name (nonproprietary): apixaban
Active ingredients: Apixaban — 2.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Indoco Remedies Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209898
Marketing start: Sep 16, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Factor Xa Inhibitors (Mechanism)
Identifiers: Product ID 14445-149_6a6e421b-6ed3-403c-b07d-09dbbd6a487cSPL ID 6a6e421b-6ed3-403c-b07d-09dbbd6a487cSPL set ID 095a08ac-cf0e-497e-a682-ddef38d6b29cRxCUI 1364435, 1364445UNII 3Z9Y7UWC1J
Pharmacologic class: Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N414445014905 followed by a unit qualifier and the quantity

Package 14445-0149-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 15, 2021. This label includes a boxed warning.

Indications (excerpt from the label)

Apixaban is a factor Xa inhibitor indicated: to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. ( 1.1 ) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. ( 1.2 ) for the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy. ( 1.3 , 1.4 , 1.5 ) 1.1 Reduction of Risk of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation Apixaban tablets are indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. 1.2 Prophylaxis of De…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209898

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209898
Product	Strength	Form · route	Labeler	Product NDC
apixaban	Apixaban 5 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-150